دورية أكاديمية

The management of clinically suspicious para‐aortic lymph node metastasis in colorectal cancer: A systematic review.

التفاصيل البيبلوغرافية
العنوان: The management of clinically suspicious para‐aortic lymph node metastasis in colorectal cancer: A systematic review.
المؤلفون: Chen, Michelle Zhiyun, Tay, Yeng Kwang, Prabhakaran, Swetha, Kong, Joseph C
المصدر: Asia Pacific Journal of Clinical Oncology; Dec2023, Vol. 19 Issue 6, p596-605, 10p
مصطلحات موضوعية: LYMPHATIC metastasis, COLORECTAL cancer, METASTASIS, CARCINOEMBRYONIC antigen, SURVIVAL rate, SURGICAL excision, LYMPHADENECTOMY
مستخلص: Approximately 1%–2% of patients with colorectal cancer (CRC) develop para‐aortic lymph node (PALN) metastases, which are typically considered markers of systemic disease, and are associated with a poor prognosis. The utility of PALN dissection (PALND) in patients with CRC is of ongoing debate and only small‐scale retrospective studies have been published on this topic to date. This systematic review aimed to determine the utility of resecting PALN metastases with the primary outcome measure being the difference in survival outcomes following either surgical resection or non‐resection of these metastases. A comprehensive systematic search was undertaken to identify all English‐language papers on PALND in the PubMed, Medline, and Google Scholar databases. The search results identified a total of 12 eligible studies for analysis. All studies were either retrospective cohort studies or case series. In this systematic review, PALND was found to be associated with a survival benefit when compared to non‐resection. Metachronous PALND was found to be associated with better overall survival as compared to synchronous PALND, and the number of PALN metastases (2 or fewer) and a pre‐operative carcinoembryonic antigen level of <5 was found to be associated with a better prognosis. No PALND‐specific complications were identified in this review. A large‐scale prospective study needs to be conducted to definitively determine the utility of PALND. For the present, PALND should be considered within a multidisciplinary approach for patients with CRC, in conjunction with already established treatment regimens. [ABSTRACT FROM AUTHOR]
Copyright of Asia Pacific Journal of Clinical Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17437555
DOI:10.1111/ajco.13924